NCT01824264View on ClinicalTrials.gov

Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LIK066

Experimental treatment doses

DRUG

Sitagliptin

Active comparator treatment dose

DRUG

Placebo

Placebo comparator dose

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY